Compressive Device to Prevent Keloïd Scars Recurrence [SCARWARS]
SCARWARS
First Study Evaluating Efficiency and Safety of a Compressive Device to Prevent Keloid Scars Recurrence After Surgery
1 other identifier
interventional
31
1 country
1
Brief Summary
SCARWARS study deals with the first on-human evaluation of a compressive device dedicated to the prevention of keloïd scars recurrence after surgery. The tested device is made with clinical grade silicon. SCARWARS is a monocentric study. 27 patients will be include and follow during one year. The primary outcome of this study is the number of keloid recurrence after treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 3, 2017
CompletedFirst Submitted
Initial submission to the registry
October 12, 2017
CompletedFirst Posted
Study publicly available on registry
October 17, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 14, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 14, 2023
CompletedSeptember 19, 2024
September 1, 2024
6.2 years
October 12, 2017
September 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Recurrence of keloid scar
Recurrence will be assessed during each visit by surgeon
12 month
Study Arms (1)
Compression device
EXPERIMENTALInterventions
interventions on patient are : * surgical excision of ear lobe keloid * application of compression device on sutured skin
Eligibility Criteria
You may qualify if:
- Patient over 18 yo;
- Patient with aer lobe keloid;
- Patient with an indication of reconstructive surgery;
- Signature of informed consent from the patient;
- Indication that the subject has understood the purpose and procedures required by the study and agrees to participate in the study and comply with the requirements and limitations inherent in this study;
- Patient with French social insurance.
You may not qualify if:
- Patient with cutaneous dermatosis or other skin pathology able to interfere with evaluated parameter (recurrence and healing quality);
- Patient with know nickel allergy;
- Patient with know silicon allergy;
- Pregnant women;
- Legal incapacity or limited legal capacity;
- Patient unlikely to cooperate in the study and / or low cooperation anticipated by the investigator;
- Patient without health insurance;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Besançon
Besançon, 25000, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Brice Chatelain, MD
Centre Hospitalier Universitaire de Besançon
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 12, 2017
First Posted
October 17, 2017
Study Start
October 3, 2017
Primary Completion
December 14, 2023
Study Completion
December 14, 2023
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share